IssuerAnnouncementDetailsV2Portlet
Actions
Arabian International Healthcare Holding Company Announces a Strategic Financial Settlement of SAR 100 million to Strengthen its Financial Position and Support Future Growth
| Element List | Explanation |
|---|---|
| Announcement Detail | Arabian International Healthcare Holding Company (“The Company”) announces the signing of a debt waiver and release agreement (“Agreement”) with Al Faisaliah Group Holding Company, the parent company of Advanced Drugs Company for Pharmaceuticals (a related party) that has majority shareholder in Tibbiyah, holding a 75% equity stake. The agreement includes a waiver of SAR 100,000,000 from Tibbiyah’s total short-term debt as of the date of this announcement is SAR 130,000,000, which was originally granted by Al Faisaliah Group Holding Company under a financing facility agreement dated April 18, 2021. The debt waiver and release agreement was signed on March 27, 2025, with the full support and approval of Tibbiyah’s Board of Directors. This initiative is aligned with the Board’s strategic objective of strengthening the Company’s financial position and accelerating its growth agenda. This move reflects the continued commitment and confidence of Tibbiyah’s key strategic shareholder and underscores strong alignment with the Company’s long-term vision in Saudi Arabia’s rapidly growing healthcare sector. The debt waiver is expected to deliver a meaningful positive impact, including a significant reduction in financing costs, enhanced cash flows, and strengthened financial position through improved leverage ratios and reducing the debt-to-equity ratio, providing greater financial flexibility to support future growth and value creation. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 31.9
Net Change 0.0 (0.0%)
Value Traded (Sar) 7,371.65
Volume Traded 233
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions